Drug Shortage Report for PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION
| Report ID | 111877 |
| Drug Identification Number | 02370166 |
| Brand name | PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION |
| Common or Proper name | PIPERACILLIN/TAZOBACTAM 3/0.375G |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | PIPERACILLIN TAZOBACTAM |
| Strength(s) | 3G 0.375G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10pk |
| ATC code | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-04-08 |
| Estimated end date | |
| Actual end date | 2022-03-30 |
| Shortage status | Resolved |
| Updated date | 2023-10-04 |
| Company comments | Item is discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-10-04 | French | Compare |
| v5 | 2023-10-04 | English | Compare |
| v4 | 2021-05-06 | French | Compare |
| v3 | 2021-05-06 | English | Compare |
| v2 | 2020-04-10 | French | Compare |
| v1 | 2020-04-10 | English | Compare |
Showing 1 to 6 of 6